IREN
IREN Limited
There isn't enough reported data to score IREN yet.
RNST
Renasant Corporation
RNST's fundamentals are strong: revenue grew 26% and its operating margin rose 17 points to 38%. At 11x earnings, it's trading in line with its usual 12x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
RNST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
RNST's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like RNST.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
RNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $36.94 | -7.4% |
| Current | 11x | $39.91 | — |
| Forward | 11x | $39.91 | — |
| Fair | 12x | $43.25 | +8.4% |
| Expensive | 17x | $60.97 | +53% |
Historical ranges are pointers, not guarantees.
RNST's PE is in its cheap range at 11.3x. If earnings grow as analysts expect, today's price would be 10.7x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
RNST Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
RNST has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
RNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.73 | +6.1% |
| Q3 2026 | $3.52 | +77% |
| Q2 2026 | $3.29 | +30% |
| Q1 2026 | $2.36 | -27% |
| Q4 2025 | $2.07 | -37% |
| Q3 2025 | $1.99 | -35% |
| Q2 2025 | $2.54 | -3.1% |
| Q1 2025 | $3.22 | +32% |
| Q4 2024 | $3.27 | +28% |
RNST has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
RNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $273M | +1.3% |
| Q2 2026 | $273.9M | +2.5% |
| Q1 2026 | $273.8M | +60% |
| Q4 2025 | $278.5M | +67% |
| Q3 2025 | $269.5M | +22% |
| Q2 2025 | $267.2M | +63% |
| Q1 2025 | $170.7M | +3.6% |
| Q4 2024 | $167.1M | +14% |
RNST's revenue has grown year over year for 10 quarters in a row: $273M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +8.5 points |
| Q2 2026 | 40% | +39 points |
| Q1 2026 | 40% | +9.9 points |
| Q4 2025 | 35% | +5 points |
| Q3 2025 | 28% | -16 points |
| Q2 2025 | 1% | -29 points |
| Q1 2025 | 30% | +0.5 points |
| Q4 2024 | 30% | +8 points |
RNST has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
RNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $161.9M | +35% |
| Q2 2026 | $76.4M | +$163.9M |
| Q1 2026 | $93.7M | -7.5% |
| Q4 2025 | $103.8M | +17% |
| Q3 2025 | $120.1M | +578% |
| Q2 2025 | -$87.5M | -$34.9M |
| Q1 2025 | $101.3M | +64% |
| Q4 2024 | $88.9M | -6.7% |
RNST has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
RNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -663K shares |
| 1 year | -3.9% | -3.7M shares |
| 3 years | +62% | +35M shares |
| 5 years | +62% | +35.1M shares |
| Available history | +57% | +33.3M shares |
RNST has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $43.1M |
| Q2 2026 | $60.5M |
| Q1 2026 | $75.8M |
| Q4 2022 | — |
| Q4 2021 | $1,000 |
| Q3 2021 | $21.3M |
| Q2 2021 | — |
| Q1 2021 | — |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
RNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
RNST's net debt is about 1.9 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like RNST.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
RNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.3 | Neutral |
| Stochastic | 34.4 | Neutral |
RNST's weekly RSI is 47 (neutral) and its Stochastic is 34 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
RNST PE vs Financial Services Sector
| Metric | RNST | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 31 | 63 | 32 pts below |
RNST is trading at 11x earnings, a 13% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
RNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.0 | 0.2% below |
| 20 week MA | $41.4 | 3.6% below |
| 50 week MA | $39.7 | 0.4% above |
| 100 week MA | $37.7 | 6% above |
| 200 week MA | $34.3 | 16% above |
RNST has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
RNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.6 | $33.3 | -6.6% |
| 2021 | $33.3 | $37.6 | +13% |
| 2022 | $37.6 | $38.2 | +1.8% |
| 2023 | $38.2 | $33.7 | -12% |
| 2024 | $33.7 | $35.8 | +6.3% |
| 2025 | $35.8 | $36.2 | +1% |
| 2026 YTD | $36.2 | $39.9 | +10% |
RNST has the edge over IREN on returns for 2026, with the stronger performance.